4 of 5 investments within oncology
March 06, 2012
Birk Venture joined the Oslo Cancer Cluster last year. The young venture company’s specialization is within the Biotech and Life Science sector in Norway and Scandinavia. Hans Ivar Robinson, Managing ...
» Read more...
Students meet with top researchers
March 05, 2012
Last week, students from Ullern High School were allowed to kill cancer cells at the Oslo University Hospital, Radium. Ten biology students were granted access to the departments of Kristian Berg and ...
» Read more...
British biotech secure exclusive rights to biomarkers
February 29, 2012
Oxford Gene Technology have licensed the rights to colorectal cancer biomarkers discovered by the Department of Cancer Prevention reserachers`s Guro E. Lind, Rolf I. Skotheim, Terje Ahlquist, Kim Andr...
» Read more...
"Research Project of the Month" to Paal F. Brunsvig
February 28, 2012
The Norwegian Cancer Society's "Research project of the month" for February 2012 went to Paal F. Brunsvig (picture to the right) from the "Department of Oncology", where he is head of the "Clinical Ca...
» Read more...
NATURE: “Norway to bring cancer-gene tests to the clinic”
February 02, 2012
An article about Norway's program for stratified cancer treatment was published in the prestige science journal Nature on February 2nd 2012. It was stated that: “Norway is set to become the first...
» Read more...
New prognostic test for improved cancer treatment
January 31, 2012
Researchers at the Oslo University Hospital have developed a gene signature that is suitable to be developed into a prognostic test for patients with stage II colorectal cancer.
The test has bee...
» Read more...
Targovax secures funding for cancer vaccine
January 30, 2012
Targovax has secured almost 13 MNOK (2.2 MUSD) from the Radium Hospital Research Foundation, Birk Venture, RO Invest and existing owners for further development of a cancer vaccine against pancreas ca...
» Read more...
Tone Yrvum has resigned from her position
January 30, 2012
Tone Yrvum has announced that she resign her position as Chief Executive Officer of Oslo Cancer Cluster to explore new challenges.
Nordic Nanovector Raises 14.3 MNOK
January 25, 2012
Oslo Cancer Cluster member Nordic Nanovector recently announced that the company has raised 14.3 million NOK in gross proceeds through a private placement. The company are developing innovat...
» Read more...
Kick-off for targeted cancer program
January 24, 2012
The research group Norwegian Cancer Genomics Consortium (NCGC) has sought funding for a three-year research project to study genetic changes in cancer tumors. Oslo Cancer Cluster is supporting this in...
» Read more...